Already confirmed speakers
Simon Baron-Cohen is Professor of Developmental Psychopathology, University of Cambridge and Fellow at Trinity College, Cambridge. He is Director, Autism Research Centre (ARC) in Cambridge. He has a degree in Human Sciences from New College, Oxford, a PhD in Psychology from UCL, and an M.Phil in Clinical Psychology at the Institute of Psychiatry, Kings College, London, and he held lectureships in these departments. He is author of Mindblindness, The Essential Difference, Prenatal Testosterone in Mind, and Zero Degrees of Empathy. He has edited scholarly anthologies including Understanding Other Minds, Synaesthesia, and The Maladapted Mind. He has written books for parents and teachers including Autism and Asperger Syndrome: The Facts, and Teaching Children with Autism to Mindread. He has celebrated autism in An Exact Mind. He is author of the DVDs Mind Reading and The Transporters, to help children with autism learn emotion recognition, both nominated for BAFTA awards. He is author of >450 scientific articles. He has supervised 32 PhD students.
In 1985 Baron-Cohen formulated and went on to test the ‘mindblindness’ theory of autism. In 1997, he formulated and went on to test the ‘fetal sex steroid’ theory of autism. He has also made contributions to the fields of autism prevalence and screening, autism genetics, autism neuroimaging, autism and technical ability, typical cognitive sex differences, and synaesthesia. In 1999 Baron-Cohen created the first UK clinic for adults with suspected Asperger Syndrome, called the CLASS clinic (Cambridge Lifespan Asperger Syndrome Service), at a time when the National Health Service (NHS) did not see the clinical need for this. This has helped over 1,000 patients to have their disability recognized, the “lost generation” of adults who had missed out on diagnosis in childhood, and has been used to create a model for similar clinical services all over the UK.
Baron-Cohen has received awards from the British Psychological Society (BPS) (Spearman Medal); the American Psychological Association (McCandless Award); the BPS (May Davison Award); the Autism Award Philadelphia Autism Association/Princeton University; the Presidents’ Award (BPS); the British Association for the Advancement of Science (BA), Joseph Lister Lecturer; the Lifetime Achievement Award, MENSA; and Kanner-Asperger Medal (German Society for Research into Autism). He is a Fellow of the BPS, the British Academy, and the American Psychological Association. He is Vice-President of the National Autistic Society, Autism Anglia, and was President, Psychology Section of the British Association and Vice-President, International Society for Autism Research (INSAR). He was Chair of the NICE Guideline Development Group for Autism (Adults), is Scientific Advisor or Patron to 6 autism charities, and a member of the Department of Health Program Board, Autism Strategy. He is Chair of the Psychology Section of the British Academy. He is co-editor in chief of the journal Molecular Autism and on the Editorial Board of many journals, including the Lancet Psychiatry. He is an Andrew D White Professor-At-Large, Cornell University, and received Doctor of Science degrees from Roehampton University and Abertay University. He is President-Elect of INSAR and an National Institute of Health Research (NIHR) Senior Investigator.
Sven Bölte, Ph.D., is professor of child and adolescent psychiatric science at the Department of Women’s and Children’s Health, Karolinska Institutet(KI), and senior clinical psychologist at the Division of Child and Adolescent Psychiatry, Center for Psychiatry Research, Stockholm County Council, Sweden. He is director of the KI Centre of Neurodevelopmental Disorders (“KIND”), editor of AUTISM, The Scandinavian Journal of Child and Adolescent Psychology and Psychiatry, and associate editor of the Journal of Autism and Developmental Disorders, and Child and Adolescent Mental Health. He is among other things founder of the Scientific Society Autism Spectrum (www.wgas.org) and international ADOS and ADI-R trainer. For his work, he has received several recognitions, such as the ”Life Watch Nordiska Priset”, ”Årets Ljus” (Society Attention), and ”Fellow of the International Society for Autism Research” (INSAR). Professor Bölte has published more than 300 original articles, reviews, book chapters, assessment and intervention tools in the field of autism spectrum, ADHD, and other neurodevelopmental conditions, and has been cited more than 13,500 times (H-index 50).
Stéfany (Stef) BONNOT-BRIEY is an autistic activist and professional.
Stéfany BONNOT-BRIEY works as trainer and referent quality & network development at the headquarters of the « Association Française de Gestion Autisme » (AFG-AUTISM). She is promoting the empowerment and quality of life of people with autism in AFG special schools and services by promoting their access to the means of compensation they need, the exercise of their rights, by building bridges towards community leaving, in order to make the notion of inclusive society more real for every autistic individual, whatever his or her level of functioning. She also practices as a counselor, trainer and coach in liberal.
Stéfany BONNOT-BRIEY was the co-founder of the SAtedI association, the first French-speaking association created in 2003 by people with autism for people with autism, to enable them to meet and help each other ; she was vice-president until 2013. She has also been vice-president of the Francophone Association of Autistic Women (AFFA) from 2016 to 2018. Stef is very committed to the empowerment of autistic people whatever support level they need. She initiated with other autistic people the creation of an association dedicated to the promotion of empowerment to choose and act on ones own life : the association of « Autistic People for a Responsible and Innovative Self-Determination » (PAARI), of which she is currently co-president. This association also promotes peer support.). She is a member of the Autism Europe council of administration.
Stéfany BONNOT-BRIEY participated in various working groups in France dedicated to the public policies related to autism : recommendations of good professional practices concerning autistic children and teenagers, recommendations of good professional practices for autistic adults, guide on the quality of life, general health, and painful problems. She recently participated in the consultations which took place prior to the « National Strategy for Autism in Neurodevelopmental Disorders» and to the steering committee of this strategy. She has held a seat of quality expert at the National Council of Mental Health (CNSM). She is a member of the « National Council for Autism Spectrum Disorders and Neurodevelopmental Disorders » established by the French government in April 2018, and she also sits in the "users" college of the « National Group of Resource Centers for Autism » (GNCRA).
Dr. Jean Decety is Irving B. Harris Distinguished Service Professor of Psychology and Psychiatry at the University of Chicago and its College. He is the head of the Social Cognitive Neuroscience Lab and the director of the Child Neurosuite. Decety is a leading scholar on the social neuroscience of empathy, morality and prosocial behavior, as well as other topics related to social decision-making. His research uses neuroimaging techniques (functional MRI and high-density EEG), combined with behavioral economics, to elucidate how biological and social factors interact in contributing to caring for the well-being of others.
His current developmental work examines the impact of resource scarcity and group dynamics on children’s moral cognition, distributive justice decisions, and considerations of fairness and equity. This project is conducted across countries in North and South America, Africa, Europe, Middle East and South East Asia.
Hilde Geurts is currently a professor by special appointment (focus Autism: Cognition across the life span) at the Department of Psychology of the University of Amsterdam. One day a week she works as a senior researcher at the "Dr. Leo Kannerhuis". She recently finished her VIDI grant (MagW NWO, 2011-2016) and her fellowship at the Netherlands Institute for Advanced Study in the Humanities and Social Sciences (NIAS) to study the effect of aging in autism. This work will be continued to a recently received VICI (MagW NWO, 2017-2022). She will focus on cognitive aging and (potentially beneficial) cognitive strategy use and autism outlook subtyping.
Hilde obtained a MSc in Neuro- and Rehabiliation psychology (1996) at the University of Nijmegen (Radboud University). Next she worked for approximately two years as a neuropsychologist in a psychiatric hospital for children. She received her PhD at the Department of Clinical Neuropsychology at the Vrije Universiteit. Her PhD project focused on Executive control in ADHD and Autism spectrum Disorders (ASD) with prof.dr. J.A. Sergeant, prof.dr. H. Roeyers and prof dr. J. Oosterlaan as advisors. In the meanwhile she worked as a lecturer at the Department of Clinical Psychology (UvA). From 2002 till 2009 she was assistant professor Clinical Neuropsychology at the Psychonomics section (currently known as Brain & Cognition, UvA) and from 2009 onwards she she was associate professor at the same department. Since 2013 she is a member of the Young Academy of the Dutch Royal Academy of Science (KNAW). In 2014 she co-founded the research network reach-aut (see www.reach-aut.nl) in which a wide range of stakeholders are together shaping autism research. For the next two years she is vice-president of the INSAR of which the annual meeting of 2018 has taken place in the Netherlands.
In Atlanta since January 2011, Ami Klin, Ph.D., Director, Marcus Autism Center and Professor and Division Chief, Division of Autism and Related Disorders, is already hard at work implementing research studies and programs that can change the lives of thousands of children with autism and their families. Autism is the fastest growing developmental disability in the U.S., affecting one in 110 children nationally—and one in 98 in Georgia. Now, Dr. Klin shares his plans for the future, from the challenges of research to creating an entirely new method for treating children.Check out his personal website